ArticleInternational journal of women's health2026
Identification of Important Risk Factors for Hypoproteinemia in Polycystic Ovaries Patients.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify the significant influencing factors of hypoproteinemia in patients with polycystic ovary syndrome. Methods: This cross-sectional investigation utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Multifactorial logistic regression analysis was employed to explore factors influencing hypoproteinemia. Receiver operating characteristic (ROC) analysis and decision curve analysis (DCA) were conducted to compare the discrimination performance and net clinical benefit of influencing factors for hypoproteinemia. The XGBoost algorithm was used to identify crucial variables. The relationships between key factors and hypoproteinemia were explored using restricted cubic spline (RCS) analysis. The stability of this relationship was verified through sensitivity analyses, including trend regression analysis and interaction tests. Results: 115 patients with polycystic ovary syndrome or polycystic ovaries were included in this study, of whom 24.348% were hypoproteinemia. Calcium, prothrombin time, and hyperlipidemia were the most stable independent associations with hypoproteinemia. Among the three, calcium had the highest AUC (0.737) and sensitivity (0.839), while hyperlipidemia showed the highest specificity (0.954). The combination of hyperlipidemia and calcium significantly enhanced the net clinical benefit compared to single hyperlipidemia or calcium. Calcium may be the more critical factor with a stable influence on hypoproteinemia than hyperlipidemia. Conclusion: The combination of calcium and hyperlipidemia may serve as a superior discriminative factor of hypoproteinemia, with calcium potentially being the more crucial factor. A value below the normal range threshold for calcium levels is a good early warning reference for hypoproteinemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.